Good Lion Imaging

What we do
Good Lion Imaging provides medical image processing services to clinicians based on standard office and web formats. Transfer your nuclear medicine brain SPECT data to us and receive a set of high quality image reports to assist in your review process. Our 3D displays are key to unlocking the information contained in these powerful SPECT images. Contact us to learn how you may benefit from our approach to presenting brain SPECT in its true glory.

A lost cause or time for a resurgence?

The Decade Of The Brain
The Decade of the Brain was a designation for 1990–1999 by U.S. president George H. W. Bush as part of a larger effort involving the Library of Congress and the National Institute of Mental Health of the National Institutes of Health “to enhance public awareness of the benefits to be derived from brain research”. During this time, brain SPECT developed into an exciting and promising new clinical application, allowing clinicians, for the first time, to observe regional brain function with a relatively simple and cost-effective, non-invasive procedure.

The Gamma Cameras
Equipment vendors invested in the development of dedicated gamma cameras for brain SPECT imaging to meet the expected increases in patient volumes. The Picker Prism 3000 triple head gamma camera, equipped with fan beam collimators, was the most successfull of them all. Even 25+ years later, it is still considered a benchmark product. In fact, some of these ‘dinosaurs’ are still in clinical operation today. Despite significant advances in gamma camera technology, the current generation of general-purpose systems, simply cannot eclipse its performance in brain imaging.

The Radio-pharmaceuticals
In that same timeframe, pharmaceutical companies developed and introduced new technetium labeled radio-pharmaceuticals with superior imaging characteristics and ease of preparation and handling. Ceretec (99mTc-HMPAO, developed by Amersham), and Neurolite (99mTc-ECD, developed by DuPont), are the most successful. The uptake of these agents in gray matter tissue is highly proportional to regional blood flow and thereby an ideal marker of regional brain function.

The Computers
At this time, we also saw the introduction of general-purpose workstation computers (remember Silicon Graphics?), which were great platforms for medical imaging processing. For the fist time it was possible, for a clinical user, to display and review brain activity in 3D displays. These displays presented these powerful SPECT images in more natural way.

The Research
Due to an increase in funding, clinical research into brain imaging with SPECT technology was booming. Nuclear medicine journals and meetings were filled to the rim with exciting presentations and new findings.

The Current Status
Yet, despite all this promise and interest, clinical brain SPECT never quite advanced to the levels that were anticipated and it soon started to fizzle out. In the early 2000s, the market moved on and interest shifted focus to newer modalities, like PET and fMRI. Today, the overall brain SPECT procedure volume accounts for less than 1% of all nuclear medicine studies in the US.

The Future
Overlooked by many, Brain SPECT is still an exciting imaging procedure that remains relevant and has not realized its full potential. Especially in Neuropsychiatry, Brain SPECT has so much to offer to those in need of reliable clinical information of the highest quality. We strive to make a contribution to its long overdue success and acceptance.